2026年9月25日星期五
M
Przegląd Świata
Światowe skróty
Talent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei AsiaTalent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei Asia

Agreement and repeatability of a novel cerebral NIRS device (RheoPatch) compared with NIRO-200NX in healthy volunteers

Źródło Nature 医学研究8 dni temu
Streszczenie treści

Agreement and repeatability of a novel cerebral NIRS device (RheoPatch) compared with NIRO-200NX in healthy volunteers

Ta strona udostępnia jedynie indeks tytułów i streszczeń; pełna treść i prawa autorskie należą do pierwotnego wydawcy. Kliknij link do oryginału, aby przeczytać.

Przejdź do oryginału
Kanał przynależności
Zdrowie
Region przynależności
Perspektywa globalna
Język oryginału
English
Numer pozycji
health-6cba3d21

Comments 0 comments

No comments yet. Be the first.

Agreement and repeatability of a novel cerebral NIRS device (RheoPatch) compared with NIRO-200NX in healthy volunteers · Przegląd Świata